Long-term assessment of macular atrophy in patients with age-related macular degeneration receiving anti–vascular endothelial growth factor
A Li, NB Rieveschl, FF Conti, FQ Silva, JE Sears… - Ophthalmology …, 2018 - Elsevier
Purpose Although intravitreal anti-vascular endothelial growth factor (VEGF) injection has
become the mainstay treatment for neovascular age-related macular degeneration (nAMD),
emerging studies suggest that anti-VEGF may be correlated with the development of
macular atrophy (MA) in chronic therapy. The purpose of the current study is to determine
the prevalence and progression of MA in nAMD treated with chronic anti-VEGF in a routine
clinical practice. Design Retrospective cohort. Participants Patients with nAMD who were …
become the mainstay treatment for neovascular age-related macular degeneration (nAMD),
emerging studies suggest that anti-VEGF may be correlated with the development of
macular atrophy (MA) in chronic therapy. The purpose of the current study is to determine
the prevalence and progression of MA in nAMD treated with chronic anti-VEGF in a routine
clinical practice. Design Retrospective cohort. Participants Patients with nAMD who were …